What is pemvidutide? An Investigational Dual-Action Medication
•
4 min read
In a Phase 2 trial, pemvidutide helped patients achieve significant weight loss while demonstrating class-leading preservation of lean muscle mass. This investigational drug, known as pemvidutide, is a novel dual-agonist peptide with potential applications in obesity, metabolic dysfunction-associated steatohepatitis (MASH), and other metabolic diseases.
